Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Australian and New Zealand Journal of Public Health|May 30, 2019
Feasibility and acceptability of opportunistic screening to detect atrial fibrillation in Aboriginal adultsRona Macniven, Josephine Gwynn, Hiroko Fujimoto, et al.
Forensic Science International|March 14, 2026
Case series involving the synthetic cathinones alpha-PHP, alpha-PiHP, MDPHP, and MDPiHP in forensic investigationsMunchelou M Gomonit, Sara E Walton, Donna M Papsun, et al.
Heart, Lung & Circulation|August 19, 2020
Atrial Fibrillation in Indigenous Australians: A Multisite Screening Study Using a Single-Lead ECG Device in Aboriginal Primary Health SettingsJosephine Gwynn, Kylie Gwynne, Rhys Rodrigues, et al.
Haematologica|December 15, 2018
Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemiaMelita Kenealy, Mark Hertzberg, Warwick Benson, et al.
British Journal of Haematology|July 25, 2003
Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled studyMichael Hedenus, Magnus Adriansson, Jesus San Miguel, et al.
Leukemia & Lymphoma|January 12, 2019
The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemiaMasa Lasica, Abbey Willcox, Kate Burbury, et al.
Leukemia & Lymphoma|May 22, 2014
An imatinib-only window followed by imatinib and chemotherapy for Philadelphia chromosome-positive acute leukemia: long-term results of the CMLALL1 trialJason D Lickliter, Kerry Taylor, Jeff Szer, et al.
Arthritis and Rheumatism|October 2, 2002
A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritisJohn Moore, Peter Brooks, Sam Milliken, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|March 24, 2012
On the need for an international effort to capture, share and use crystallization screening dataJanet Newman, Evan E Bolton, Jochen Müller-Dieckmann, et al.
Blood|July 17, 2004
Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutationsSusan Branford, Zbigniew Rudzki, Ian Parkinson, et al.
Pageof 8